Boosting Domestic Pharmaceutical Manufacturing: A Golden Opportunity for Investors
Vietnam's healthcare sector has made significant progress over the past decades, driven by government reforms and increasing private sector participation. Despite these achievements, the healthcare system still faces three major challenges. First, primary care remains underutilized, while hospitals are overwhelmed with patients. Second, there is a shortage of healthcare professionals, particularly nurses. Lastly, persistent funding gaps lead to substantial out-of-pocket expenses for patients.
These challenges create numerous opportunities for investors to engage in the transformation of Vietnam’s healthcare system while generating significant returns. Notably, pharmaceutical manufacturing plays a crucial role. Vietnam's reliance on expensive imported specialty drugs poses a challenge for managing the national healthcare budget. In response, the government has strongly encouraged investment in domestic pharmaceutical production, particularly for chronic disease treatments and high-cost branded medications. This presents a golden opportunity for investors who can enhance production standards to meet certifications such as the EU-GMP or Japan-GMP.
Read the full article at: https://vir.com.vn/how-can-private-investments-unlock-vietnams-healthcare-114809-114809.html
